Nirman Agri Genetics LtdQ4 FY25
Nirman Agri Genetics Ltd Q4 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹40.5P/E: 1.4Market Cap: ₹39 CrSector: Agricultural Food & other Products
Management growth scorecard
Revenue
Category 1
Margin
Category 3
Fundraise
No
Order
Yes
Capex
Yes
3 of 5 growth signals are positive.
Full analysisRevenue guidance
Category 1- →Nirman Agri Genetics targets a revenue growth of 150% to 200% annually for the next 5 years.
- →Current revenue stands at INR173 crores, with guidance to reach INR220-250 crores in FY25.
- →Expected revenue:
- → - INR432 crores in two years
- → - INR1,000 crores in the next two years
- → - Approximately INR2,000 crores in five years
- →No plan to reach INR20,000 crores by 2030 (clarified miscalculation).
- →Growth driven by expanding market share, increased production capacity from own processing plant, and new initiatives like Krushi Dham physical stores.
- →Operating margins expected to improve to 14%-15% with full utilization of new processing facility.
- →Growth will be sustainable and spread throughout the year despite seasonality.
Margin guidance
Category 3- →Revenue growth guidance is strong, targeting 150% to 200% growth annually over the next five years.
- →The company expects to grow from around INR 200 crores currently to INR 2,000 crores in revenue within five years.
- →Net profit margins are projected to improve, aiming for 14-15% PAT margins, up from current 10-11%.
- →Full utilization of the company's own processing plant is expected to contribute to margin expansion in upcoming periods.
- →Q3 FY25 revenue rose 223% YoY, and net profit increased 114% YoY, signaling operational scalability and strong earnings potential.
- →No immediate fundraising planned; capital allocation will depend on future situation as the company scales.
- →Earnings per share (EPS) is expected to benefit from the growth in revenues and margins, reflecting sustainable profitability improvements.
3 more insights locked — sign up free to unlock
Fundraise plans
No- →Currently, Nirman Agri Genetics Limited has no immediate plans for fundraising through debt or equity.
- →Decisions on fundraising will be made depending on the situation at the relevant time.
- →The company is focused on its growth strategy and prefers to take fundraising decisions based on need as they scale.
- →There is no ongoing fundraising activity announced as of the February 27, 2025 conference call.
Order book
Yes- →Current order book for Kharif season: INR 150 crores (unexecuted orders as of February 2025).
- →Current order book for Rabi season: INR 98 crores.
- →Combined order book (Kharif + Rabi): INR 248 crores approximately.
- →Order book expected to increase by April 2025.
- →Company standing on INR 173 crores revenue for 9 months FY25.
- →Expected to meet guidance of INR 220-250 crores revenue for full FY25.
- →Strong revenue growth indicating timely execution of order book.
Capex plans
Yes- →The company has made a capex of about INR 3.5 crores for their factory.
- →The factory has a revenue potential of INR 500 crores with an expected PAT margin of around 15%.
- →No specific future capex plans were explicitly mentioned for new factories or expansions.
- →For the planned growth to INR 2,000 crores revenue in the next five years, no current fundraising or investment plans are in place; decisions will be made based on the situation at that time.
- →Krushi Dham physical stores are planned as a strategic initiative, with about 25 stores targeted initially, dependent on certifications and licensing.
- →The company aims to focus on certifications, licensing, and corporate governance improvements to support future growth.
How does Nirman Agri Genetics Ltd rank vs peers in Agricultural Food & other Products?
Pro feature1Nirman Agri Genetics Ltd
Rev 1Mar 3
See full Agricultural Food & other Products sector rankings